Serum Institute’s indigenous pneumonia vaccine gets DCGI approval1 min read . Updated: 15 Jul 2020, 06:09 PM IST
- As per the government’s clinical trial registry, the first phase of the trial was conducted in 2013 in 34 young Indian adults, while the second phase in 114 toddlers of 12-15 months
NEW DELHI: The Drug Controller General of India V.G. Somani has approved Serum Institute of India Pvt Ltd’s indigenous pneumococcal polysaccharide conjugate vaccine, making it the first indigenously developed vaccine against pneumonia, the government said in a statement on Wednesday.
Select your Category